The IPO Buzz
IPO Calendar
Last Week's IPO Traffic
Pricings
2015 Pricings
Last 100 IPOs
Last 12 Months
IPOs by Managers
By Industry
Secondary Offerings
IPO Pipeline
SCOOP Ratings
IPOs Recently Filed
IPOs by Managers
By Industry
Secondary Offerings
Archives
SCOOP Track Record From 2000 to Present
IPO Traffic by Week
IPO Index
TriVascular Technologies 
General Information
Business: We are a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms, or AAA. Our mission is to help physicians improve the lives of patients suffering from aortic disease through excellence in research, product development, manufacturing, sales and service. We developed our technology platform leveraging engineering principles utilized in many industries, including aerospace, aircraft and automotive, and applied these concepts with the goal of designing an optimal solution for AAA therapy to address unmet clinical needs. For example, we leveraged our knowledge of fluid mechanics in developing our sealing technology. The Ovation System, our solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a new stent graft platform, providing an innovative and effective alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 253 Founded: 1998
Contact Information
Address: 3910 Brickway Blvd., Santa Rosa, CA 95403, US
Phone: 707-543-8800
Web Address: www.trivascular.com
View Prospectus: TriVascular Technologies
Financial Information
Market Cap: $ 270.6 mil
Revenues: $ 19.5 mil (last 12 months)
Net Income: $ -50.3 mil (last 12 months)
IPO Profile
Symbol: TRIV
Shares (millions): 6.5
Price Range: $12.00 - $12.00
Est.$ Volume $ 78.0 mil
Manager / Joint Managers J.P. Morgan/ Credit Suisse
Co Managers Canaccord Genuity/ Stifel
Expected to Trade 4/16/2014
Status Priced
SCOOP RATING Available only to Subscribers
RATING CHANGE Available only to Subscribers


 
© 2024 IPOSCOOP.com All rights reserved.